Food and Drug Administration Issues Consumer Update on CBD.

Public interest in CBD derived from hemp is at an all time high (no pun intended) these days. Products containing CBD seem to be everywhere as entrepreneurs jump on the bandwagon. On November 25th, the US Food and Drug Administration released a Consumer Update to inform the public about CBD safety.

Key Points From The Update:

* The FDA has approved only one CBD product, a prescription drug product to treat two rare, severe forms of epilepsy.

* It is currently illegal to market CBD by adding it to a food or labeling it as a dietary supplement.

* The FDA has seen only limited data about CBD safety and these data point to real risks that need to be considered before taking CBD for any reason.

* Some CBD products are being marketed with unproven medical claims and are of unknown quality.

* CBD products are also being marketed for pets and other animals. The FDA has not approved CBD for any use in animals and the concerns regarding CBD products with unproven medical claims and of unknown quality equally apply to CBD products marketed for animals.

Read the full Consumer Update here: